Substrates for peptidase S09.001: prolyl oligopeptidase
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abz-Asn-Lys-Pro-Arg-Arg-Pro-Gln-EDDnp | Abz-Asn-Lys-Pro-Arg-Arg-Pro+Gln-EDDnp | S | Pro | Arg | Arg | Pro | Gln | EDD | - | - | Oliveira et al., 2001 | |||||
| acyl-CoA-binding protein | P11030 | 34-51 | Gln-Ala+Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys | N | - | - | Gln | Ala | Thr | Val | Gly | Asp | Leprince et al., 2006 | |||
| acyl-CoA-binding protein | P11030 | 34-51 | Gln-Ala-Thr-Val+Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys | N | Gln | Ala | Thr | Val | Gly | Asp | Val | Asn | Leprince et al., 2006 | |||
| adenylate kinase isoenzyme 1 | P00571 | 164-183 | Tyr-Glu-Lys-Arg-Gly-Ile-Val-Arg-Lys-Val-Asn-Ala+Glu-Gly-Ser-Val-Asp-Asp-Val-Phe | P | MS | Lys | Val | Asn | Ala | Glu | Gly | Ser | Val | Brandt et al., 2005 | ||
| alpha-melanocyte-stimulating hormone | P01189 | 138-150 | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro+Val-NH2 | N | Trp | Gly | Lys | Pro | Val | NH2 | - | - | Ito et al., 2004 | |||
| alpha-S1-casein | P02662 | 16-214 | peptide-Pro42+Phe-peptide | P | Phe | Val | Ala | Pro | Phe | Pro | Glu | Val | Clare & Swaisgood, 2000 | 24454 | ||
| alpha/beta-gliadin MM1 | P18573 | 89-101 | Pro-Gln-Pro-Gln-Leu-Pro+Tyr-Pro-Gln-Pro-Gln-Leu-Pro | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 89-101 | Pro-Gln-Pro-Gln-Leu-Pro-Tyr-Pro+Gln-Pro-Gln-Leu-Pro | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro82+Gln-peptide | P | MS | Gln | Pro | Phe | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro87+Tyr-peptide | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro89+Gln-peptide | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro94+Tyr-peptide | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro96+Gln-peptide | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro101+Tyr-peptide | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro103+Gln-peptide | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro80+Phe-peptide | P | MS | Gln | Leu | Gln | Pro | Phe | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro82+Gln-peptide | P | MS | Gln | Pro | Phe | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro84+Gln-peptide | P | MS | Phe | Pro | Gln | Pro | Gln | Leu | Pro | Tyr | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro87+Tyr-peptide | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro89+Gln-peptide | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Gln92+Leu-peptide | P | MS | Pro | Gln | Pro | Gln | Leu | Pro | Tyr | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro94+Tyr-peptide | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro96+Gln-peptide | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Leu | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro98+Gln-peptide | P | MS | Tyr | Pro | Gln | Pro | Gln | Leu | Pro | Tyr | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro101+Tyr-peptide | P | MS | Pro | Gln | Leu | Pro | Tyr | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro103+Gln-peptide | P | MS | Leu | Pro | Tyr | Pro | Gln | Pro | Gln | Pro | Shan et al., 2004 | ||
| alpha/beta-gliadin MM1 | P18573 | 76-108 | peptide-Pro105+Gln-Pro-Phe | P | MS | Tyr | Pro | Gln | Pro | Gln | Pro | Phe | - | Shan et al., 2004 | ||
| aminoacyl-Ala bond | peptide+Ala-peptide | N | - | - | - | NPe | Ala | CPe | - | - | Ito et al., 2004 | |||||
| aminoacyl-Ser bond | peptide+Ser-peptide | N | - | - | - | NPe | Ser | CPe | - | - | Ito et al., 2004 | |||||
| angiotensin-2 | P01019 | 34-41 | Asp-Arg-Val-Tyr-Ile-His-Pro+Phe | N | Tyr | Ile | His | Pro | Phe | - | - | - | Koida & Walter, 1976 | 3723 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro+Pro-Gly-Phe-Ser-Pro-Phe-Arg | N | - | - | Arg | Pro | Pro | Gly | Phe | Ser | Ito et al., 2004 | 17662 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro+Gly-Phe-Ser-Pro-Phe-Arg | N | - | Arg | Pro | Pro | Gly | Phe | Ser | Pro | Koida & Walter, 1976 | 17663 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro+Phe-Arg | N | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Koida & Walter, 1976 | 21614 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro+Phe-Arg | P | Gly | Phe | Ser | Pro | Phe | Arg | Gly | Gly | De Camargo et al., 1982 | 21626 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro+Phe-Arg | N | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Mäkinen et al., 1995 | |||
| bradykinin-potentiating factor | Glp-Gly-Gly-Trp-Pro+Arg-Pro-Gly-Pro-Glu-Ile-Pro-Pro | N | Gly | Gly | Trp | Pro | Arg | Pro | Gly | Pro | Koida & Walter, 1976 | |||||
| bradykinin-potentiating factor | Glp-Gly-Gly-Trp-Pro-Arg-Pro+Gly-Pro-Glu-Ile-Pro-Pro | N | Trp | Pro | Arg | Pro | Gly | Pro | Glu | Ile | Koida & Walter, 1976 | |||||
| bradykinin-potentiating factor | Glp-Gly-Gly-Trp-Pro-Arg-Pro-Gly-Pro+Glu-Ile-Pro-Pro | N | Arg | Pro | Gly | Pro | Glu | Ile | Pro | Pro | Koida & Walter, 1976 | |||||
| dynorphin A(1-13) | P01214 | 209-221 | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro+Lys-Leu-Lys-Trp-Asp-Asn-Gln | N | Arg | Ile | Arg | Pro | Lys | Leu | Lys | Trp | Ito et al., 2004 | |||
| gonadoliberin | Gln-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro+Gly | N | Gly | Leu | Arg | Pro | Gly | - | - | - | Ito et al., 2004 | |||||
| gonadoliberin-1 | P01148 | 24-33 | peptide-Pro32+Gly-peptide | P | Gly | Leu | Arg | Pro | Gly | Gly | Gly | Gly | De Camargo et al., 1982 | 21628 | ||
| gonadoliberin-1 | P01148 | 24-33 | Gln-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro+Gly | P | CS | Gly | Leu | Arg | Pro | Gly | Gly | Lys | Arg | Lew et al., 1994 | ||
| hemoglobin subunit alpha | P01965 | 110-122 | Ala-Ala-His-His-Pro-Asp-Asp-Phe-Asn-Pro+Ser-Val-His | P | MS | Asp | Phe | Asn | Pro | Ser | Val | His | Ala | Brandt et al., 2005 | ||
| hemoglobin subunit beta | P02067 | 116-130 | Ala-Arg-Arg-Leu-Gly-His-Asp-Phe-Asn-Pro+Asn-Val-Gln-Ala-Ala | P | MS | Asp | Phe | Asn | Pro | Asn | Val | Gln | Ala | Brandt et al., 2005 | ||
| luteinizing hormone-releasing hormone | Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro+Gly-NH2 | N | Gly | Leu | Arg | Pro | Gly | NH2 | - | - | Ito et al., 2004 | |||||
| myelin basic protein | P81558 | 70-89 | Ser-Leu-Pro-Gln-Lys-Ala-Gln-His-Gly-Arg-Pro+Gln-Asp-Glu-Asn-Pro-Val-Val-His-Phe | P | MS | His | Gly | Arg | Pro | Gln | Asp | Glu | Asn | Brandt et al., 2005 | ||
| oxytocin | P01178 | 20-28 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro+Leu-Gly-NH2 | N | Gln | Asn | Cys | Pro | Leu | Gly | NH2 | - | Koida & Walter, 1976 | 3722 | ||
| substance P | P20366 | 58-68 | peptide-Pro4+Gln-peptide | N | Arg | Pro | Lys | Pro | Gln | Gln | Phe | Phe | Mäkinen et al., 1995 | 21565 | ||
| Suc-Ala-Pro-Ala-NHPhNO2 | Suc-Ala-Pro-Ala+NHPhNO2 | S | Suc | Ala | Pro | Ala | NAN | - | - | - | Shan et al., 2004 | |||||
| Suc-Ala-Pro-Ala-NHPhNO2 | Suc-Ala-Pro-Ala+NHPhNO2 | S | Suc | Ala | Pro | Ala | NAN | - | - | - | Shan et al., 2004 | |||||
| Suc-Ala-Pro-Ala-NHPhNO2 | Suc-Ala-Pro-Ala+NHPhNO2 | S | Suc | Ala | Pro | Ala | NAN | - | - | - | Shan et al., 2004 | |||||
| Suc-Gly-Pro-NHMec | Suc-Gly-Pro+NHMec | S | - | Suc | Gly | Pro | AMC | - | - | - | ||||||
| thymosin beta-4 | P62328 | 2-44 | peptide-Pro5+Asp-peptide | P | CS | Ser | Asp | Lys | Pro | Asp | Met | Ala | Glu | Cavasin et al., 2004 | ||
| vasopressin | Cys-Tyr-Phe-Gln-Asn-Cys-Pro+Arg-Gly | N | Gln | Asn | Cys | Pro | Arg | Gly | - | - | Ito et al., 2004 | |||||
| Z-Gly-Pro-Leu-Gly | Z-Gly-Pro+Leu-Gly | S | - | Z | Gly | Pro | Leu | Gly | - | - | Ito et al., 2004 | |||||
| Z-Gly-Pro-NHMec | Z-Gly-Pro+NHMec | S | - | Z | Gly | Pro | AMC | - | - | - | Ito et al., 2004 | |||||
| Z-Gly-Pro-NHNap | Z-Gly-Pro+NHNap | S | - | Z | Gly | Pro | NAP | - | - | - | Ito et al., 2004 | |||||
| Z-Gly-Pro-NHPhNO2 | Z-Gly-Pro+NHPhNO2 | S | - | Z | Gly | Pro | NAN | - | - | - | Ito et al., 2004 | |||||
| Z-Gly-Pro-NHPhNO2 | Z-Gly-Pro+NHPhNO2 | S | - | Z | Gly | Pro | NAN | - | - | - | Mäkinen et al., 1994 |
